Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings

30 11 月, 2025

One Min Read

18 Views

原文: https://finance.yahoo.com/news/oppenheimer-maintains-outperform-rating-immunovant-182911548.html

Last Update: 30 11 月, 2025

Written By

Other Articles

Previous

Under Armour (UA) Strengthens Core Business Despite Curry Partnership Ending

Next

Jim Cramer on Keurig Dr Pepper: “They’re Doing Some Good Things”

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept